España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Kiniksa Pharmaceuticals
KNSA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$20.59
0.10
0.49%
At close: -
$20.59
-0.00050
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
Kiniksa Pharmaceuticals (KNSA) Forecast
News
Earnings
Kiniksa Pharmaceuticals (KNSA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Kiniksa Pharmaceuticals (NASDAQ:KNSA) Stock
Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 05, 2024
JP Morgan Maintains Overweight on Kiniksa Pha...
Benzinga Newsdesk
Wednesday, October 30, 2024
Evercore ISI Group Maintains Outperform on Ki...
Benzinga Newsdesk
Tuesday, October 29, 2024
Kiniksa Pharmaceuticals shares are trading lo...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Expects 2024 Arcalyst...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q3 2024 GAAP EPS $(0....
Benzinga Newsdesk
Monday, October 28, 2024
Exploring Kiniksa Pharmaceuticals's Earnings Expectations
Benzinga Insights
Friday, September 13, 2024
Jefferies Initiates Coverage On Kiniksa Pharm...
Benzinga Newsdesk
Tuesday, July 23, 2024
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Wedbush Maintains Outperform on Kiniksa Pharm...
Benzinga Newsdesk
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Kiniksa Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Kiniksa Expects 2024 Arcalyst Net Product Rev...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q2 2024 GAAP EPS $(0....
Benzinga Newsdesk
Tuesday, July 09, 2024
Kiniksa Pharmaceuticals Commences Enrollment ...
Benzinga Newsdesk
Monday, June 17, 2024
Kiniksa Pharmaceuticals Sponsors American Hea...
Benzinga Newsdesk
Friday, June 14, 2024
Kiniksa Pharmaceuticals - Expects Redomicilia...
Benzinga Newsdesk
Friday, May 03, 2024
Wells Fargo Initiates Coverage On Kiniksa Pha...
Benzinga Newsdesk
Wednesday, May 01, 2024
JP Morgan Maintains Overweight on Kiniksa Pha...
Benzinga Newsdesk
Wednesday, April 24, 2024
Evercore ISI Group Maintains Outperform on Ki...
Benzinga Newsdesk
Tuesday, April 23, 2024
Kiniksa Expects 2024 Arcalyst Net Product Rev...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q1 2024 GAAP EPS $(0....
Benzinga Newsdesk
Earnings Scheduled For April 23, 2024
Benzinga Insights
Wednesday, February 28, 2024
Kiniksa Expects 2024 ARCALYST Net Product Rev...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q4 EPS $0.35 Beats $(0.14) Estimate, Sales $83.39M Beat $72.02M Estimate
Happy Mohamed
Earnings Scheduled For February 28, 2024
Benzinga Insights
Tuesday, February 27, 2024
Earnings Outlook For Kiniksa Pharmaceuticals
Benzinga Insights
Thursday, January 04, 2024
Kiniksa Pharmaceuticals Says ARCALYST (rilona...
Benzinga Newsdesk
Tuesday, January 02, 2024
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Wedbush Maintains Outperform on Kiniksa Pharm...
Benzinga Newsdesk
Tuesday, October 31, 2023
Kiniksa Pharmaceuticals Q3 GAAP EPS $(0.20) V...
Benzinga Newsdesk
Earnings Scheduled For October 31, 2023
Benzinga Insights
Monday, October 30, 2023
Earnings Outlook For Kiniksa Pharmaceuticals
Benzinga Insights
Monday, September 11, 2023
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, August 21, 2023
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Friday, July 28, 2023
Chief Medical Officer of Kiniksa Pharmaceuticals Makes $555K Sale
Benzinga Insights
Wednesday, July 26, 2023
Goldman Sachs Maintains Buy on Kiniksa Pharma...
Benzinga Newsdesk
Tuesday, July 25, 2023
Crude Oil Up 1%; Verizon Earnings Beat Views
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Kiniksa Pharmaceuticals shares are trading hi...
Benzinga Newsdesk
Xerox, Logitech International, Packaging Corporation of America And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
UPDATE: Kiniksa Pharmaceuticals Q2 Adj EPS $(0.02) Beats $(0.17) Estimate, Sales $71.47M Beat $52.20M Estimate
Happy Mohamed
Kiniksa Forecasts Arcalyst Revenues Of $220M-...
Benzinga Newsdesk
Kiniksa Pharmaceuticals Q2 Adj EPS $(0.02) Be...
Benzinga Newsdesk
Earnings Scheduled For July 25, 2023
Benzinga Insights
Monday, July 24, 2023
Earnings Outlook For Kiniksa Pharmaceuticals
Benzinga Insights
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, June 05, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Monday, May 22, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Thursday, March 09, 2023
JP Morgan Maintains Overweight on Kiniksa Pha...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch